Source:http://linkedlifedata.com/resource/pubmed/id/20521253
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2011-1-31
|
pubmed:abstractText |
To investigate the association between the potentially functional polymorphisms in IL12A and IL12B, HBV infection and risk of hepatocellular carcinoma in a Chinese population, we genotyped three polymorphisms, rs568408 (3'UTR G>A), rs2243115 (5'UTR T>G) in IL12A and rs3212227 (3'UTR A>C) in IL12B in a case-control study of 869 hepatocellular carcinoma (HCC) cases and 891 cancer-free controls. We found that the IL12A rs568408 GA/AA variant genotypes were associated with a significantly increased risk of HCC (adjusted odds ratio (OR) = 1.53, 95% confidence interval (CI) = 1.17-2.00), compared with the wild-type GG homozygote. In the stratified analyses, the increased risk of HCC associated with rs568408 GA/AA was more evident in patients who were negative for HBsAg (adjusted OR = 1.71, 95% CI = 1.23-2.39). However, no significant associations between IL12A rs2243115 T/G, IL12B rs3212227 A/C and risk of HCC were observed. Our findings indicate that IL12A rs568408 may contribute to the risk of HCC and modify HCC risk associated with HBV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1097-0215
|
pubmed:author |
pubmed-author:ChenJianguoJ,
pubmed-author:HuZhibinZ,
pubmed-author:JiGuozhongG,
pubmed-author:JosKK,
pubmed-author:KlosIu SIuS,
pubmed-author:LiuJibinJ,
pubmed-author:LiuShengS,
pubmed-author:LiuZhengZ,
pubmed-author:ShenHongbingH,
pubmed-author:ShiHaibinH,
pubmed-author:ZhangYixinY,
pubmed-author:ZhuJianJ
|
pubmed:copyrightInfo |
Copyright © 2010 UICC.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1692-6
|
pubmed:meshHeading |
pubmed-meshheading:20521253-Adult,
pubmed-meshheading:20521253-Aged,
pubmed-meshheading:20521253-Carcinoma, Hepatocellular,
pubmed-meshheading:20521253-Case-Control Studies,
pubmed-meshheading:20521253-China,
pubmed-meshheading:20521253-Female,
pubmed-meshheading:20521253-Genotype,
pubmed-meshheading:20521253-Hepacivirus,
pubmed-meshheading:20521253-Hepatitis B virus,
pubmed-meshheading:20521253-Homozygote,
pubmed-meshheading:20521253-Humans,
pubmed-meshheading:20521253-Interleukin-12,
pubmed-meshheading:20521253-Liver Neoplasms,
pubmed-meshheading:20521253-Male,
pubmed-meshheading:20521253-Middle Aged,
pubmed-meshheading:20521253-Polymorphism, Genetic,
pubmed-meshheading:20521253-Risk
|
pubmed:year |
2011
|
pubmed:articleTitle |
IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.
|
pubmed:affiliation |
Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|